LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2021

Mar 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2021-03-15

Reporting Person: Tessmer James F (VP, Finance & Accounting)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-15	Common Stock	S	10912	$6.9043	Disposed	71766	Direct
2021-03-15	Common Stock	M	12000	$3.31	Acquired	83766	Direct
2021-03-15	Common Stock	S	12000	$6.925	Disposed	71766	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-15	Stock Option (Right to Buy)	$3.31	M	12000	Disposed	2030-02-06	Common Stock (12000)	Direct

Footnotes

F1: Executed in multiple trades at prices ranging from $6.90 to $6.92 per share. The reported price reflects the weighted average sale price. Mr. Tessmer hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: Executed in multiple trades at prices ranging from $6.91 to $6.955. The reported price reflects the weighted average sale price. Mr. Tessmer hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.